Inflammation News and Research

RSS

Experts clarify MS subtypes to improve care and access to treatments

An international committee of multiple sclerosis (MS) experts has clarified their previously published descriptors of the different courses of MS and disease activity.

11 Jun 2020

Camelina sativa oil and fatty fish have major beneficial effect on lipid metabolism

Camelina sativa oil and fatty fish are rich in polyunsaturated omega-3 fatty acids, but their health benefits seem to differ.

11 Jun 2020

Hydroxychloroquine suppresses 'trained immunity'

A new study published on the preprint server medRxiv in June 2020 shows that the drug hydroxychloroquine (HCQ) suppresses a form of immunity called ‘trained immunity,’ with repercussions for its potential use to treat COVID-19.

11 Jun 2020

COVID-19 mouse model could accelerate the search for treatments, vaccines

The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.

10 Jun 2020

Key enzyme that contributes to eczema identified

Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder's debilitating effects.

10 Jun 2020

UVA Health increasing access to food allergy clinical trials and expanding research

UVA Health and UVA Children's are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research, following their selection to a national food-allergy clinical network.

10 Jun 2020

Study: Cigarette smoking can increase the risk of stroke in African Americans

African Americans who smoke are nearly 2.5 times more likely to have a stroke than those who never smoked, while former smokers show a similarly lower risk as never smokers, according to a new study funded by the National Institutes of Health.

10 Jun 2020

Research demonstrates novel pathway regulating the underlying mechanism of NASH

CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems that improve the accuracy and efficiency of drug discovery, today announced the publication of co-authored research led by researchers at the University of Cambridge in Nature Metabolism, identifying a novel pathway that regulates the underlying mechanism of Non-Alcoholic Steatohepatitis, potentially a new therapeutic target.

10 Jun 2020

Immuno-oncology may accelerate the development of treatments for COVID-19

Researchers at Roswell Park Comprehensive Cancer Center have been actively engaged in the effort to develop treatments or other control strategies that can help communities worldwide to address the impacts of the COVID-19 pandemic.

10 Jun 2020

Detachable microneedle depots deliver therapeutic stem cells to injured tissue sites

Mesenchymal stem cells (MSCs) are multipotent in that they naturally replenish the cell types that build our bone, cartilage and adipose tissues.

10 Jun 2020

Study explores the negative consequences of social isolation

Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.

10 Jun 2020

Cys-C protein can predict risk of cardiovascular and renal diseases

The glomerular filtration rate (GFR) is normally specified as a measure of kidney function. The GFR is the volume of blood that the kidneys filter per minute (the unit of measurement, in relation to a standardized body surface area, is therefore ml/min/1.73 m2).

10 Jun 2020

Identifying key predictors of mortality in young dialysis patients

The percentage of children and young people who have severe kidney disease and require renal replacement therapy (RRT) is relatively low at approximately 2% .

9 Jun 2020

A drug to treat harsh complications of coronavirus infection is registered in Russia

Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.

9 Jun 2020

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease.

9 Jun 2020

High-salt diet may modulate the gut microbiome

Particularly in females with untreated hypertension, reducing salt intake to what's considered a healthier level appears to be good for both their gut microbiome and their blood pressure, scientists report.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease.

8 Jun 2020

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

In a new study available on the preprint server bioRxiv*, a multinational research group demonstrated how monoclonal antibodies strongly inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro at even sub-nanomolar concentrations. This makes them a prime candidate for the treatment of coronavirus disease (COVID-19).

8 Jun 2020

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Obesity affects more than 40 percent of adults in the United States and 13 percent of the global population.

8 Jun 2020

Inflammation News and Research

Experts clarify MS subtypes to improve care and access to treatments

Camelina sativa oil and fatty fish have major beneficial effect on lipid metabolism

Hydroxychloroquine suppresses 'trained immunity'

COVID-19 mouse model could accelerate the search for treatments, vaccines

Key enzyme that contributes to eczema identified

UVA Health increasing access to food allergy clinical trials and expanding research

Study: Cigarette smoking can increase the risk of stroke in African Americans

Research demonstrates novel pathway regulating the underlying mechanism of NASH

Immuno-oncology may accelerate the development of treatments for COVID-19

Detachable microneedle depots deliver therapeutic stem cells to injured tissue sites

Study explores the negative consequences of social isolation

Cys-C protein can predict risk of cardiovascular and renal diseases

Identifying key predictors of mortality in young dialysis patients

A drug to treat harsh complications of coronavirus infection is registered in Russia

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

High-salt diet may modulate the gut microbiome

COVID-19 produces lung inflammation in non-human primate experiments

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News